Ukrainian biomedical tissue-engineered product for treatment of bone critical sized defects and avn: manufacturing and first-in-human clinical outcomes
Ukrainian biomedical tissue-engineered product for treatment of bone critical sized defects and avn: manufacturing and first-in-human clinical outcomes
[version 1; not peer reviewed]The study was conducted by employees from Medical company ilaya (A.A. PARTNERS LLC.). Ukrainian volunteer center “Peoples project” provided financial support as charity for study participants, who suffered during the fighting in the East of Ukraine. ILAYA SCIENCE LLC. is coordinating the research and processing of statistical data obtained during the study by the Agreement on cooperation with A.A. PARTNERS LLC. The poster was created by the employee from ILAYA SCIENCE LLC. (Kristina Hantseva). According to the research data was created a Ukrainian patent "MEDICAL PRODUCT BASED ON HUMAN CELLS FOR CORRECTION OF OSTEOREPARATIVE PROCESSES" No. 115089 and an application PCT/UA2016/000128 “METHOD OF THE OSTEOREPARATIVE PROCESSES’ CORRECTION AND /OR BONE DEFECT RESTORATION BY MEANS OF HUMAN CELL-BASED MEDICINAL PRODUCTS (CELL AND/OR TISSUE TRANSPLANTS) AND/OR METHOD OF THEIR MANUFACTURING”. There are no political, religious, or ideological competing interests.
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
All commenters must hold a formal affiliation as per our Policies. The information that you give us will be displayed next to your comment.
User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.
Use of this website is subject to the F1000 Research Limited (F1000) General Terms and Conditions.
Submission of user comments to this website is subject to additional Terms and Conditions. By clicking "I accept the User Comment Terms and Conditions" before you submit your first comment, you agree to be bound by these conditions every time you submit a comment.
Terms relating to user comments